IL DONG PHARMACEUTICAL (249420) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, IL DONG PHARMACEUTICAL (249420) reported revenue of 566.9 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025566.9 billion KRW19.5 billion KRW23.7 billion KRW[source]
2024614.9 billion KRW13.1 billion KRW-12.4 billion KRW[source]
2023600.8 billion KRW-53.9 billion KRW-81.0 billion KRW[source]
2022637.7 billion KRW-73.5 billion KRW-142.2 billion KRW[source]
2021560.1 billion KRW-55.5 billion KRW-101.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025579.1 billion KRW305.2 billion KRW273.9 billion KRW[source]
2024571.3 billion KRW390.8 billion KRW180.6 billion KRW[source]
2023569.2 billion KRW402.9 billion KRW166.2 billion KRW[source]
2022637.2 billion KRW446.6 billion KRW190.6 billion KRW[source]
2021689.9 billion KRW537.9 billion KRW152.0 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice